vimarsana.com
Home
Live Updates
Corticosteroid taper
Live Breaking News & Updates on Corticosteroid taper
FDA Approves First Biologic Treatment for Polymyalgia Rheumatica
The interleukin-6 receptor antagonist sarilumab (Kevzara) will be indicated in adults who have had an inadequate response to corticosteroids or could not tolerate a corticosteroid taper.
Georged-yancopolous
,
Drug-administration
,
American-college-of-rheumatology
,
Medscape-medical-newspreviously
,
Rheumatoid-arthritis
,
A
,
Biologic-therapy
,
Corticosteroid
,
Corticosteroid-taper
,
Polymyalgia-rheumatica
,
Neutropenia